Tom Powles and Axel Bex
Jul 4, 2025, 02:48
Tom Powles: Axel Bex Discussing the Role of Partial Nephrectomy in Renal Cancer
Tom Powles, Head of Solid Tumor Research at Barts Cancer Institute, shared a post on X:
“Axel Bex discussing the role of partial nephrectomy in renal cancer and highlighting difficulties in completing investigator-led studies.
While partial nephrectomy data looks better and is SOC, the detail of the largest trial (OPERA) shows it did not meet statistical significance.”
More posts featuring Tom Powles on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 16:47
Sep 7, 2025, 16:30
Sep 7, 2025, 16:25